Energy Devices for Rejuvenation (NCT03767972) | Clinical Trial Compass
TerminatedNot Applicable
Energy Devices for Rejuvenation
Stopped: The study procedures and enrollment were stopped due to COVID-19 restrictions on non-essential research. The study was not able to continue due to change in research personnel after research was able to resume.
âś“. Subjects between the ages of 18-85 years old, at the time of consent.
âś“. Subjects may be male or female.
âś“. Subjects with Fitzpatrick Skin type I-III (Fraxel Restore, Helios III, Pico) or I-VI (Halo, ThermiVa, DiVa).
âś“. Subjects must be able and willing to give written informed consent and to comply with the requirements of this protocol. The consent form has been standardized in English. For those patients who do not read and understand English, a consent form will be standardized and provided in a language that they read and understand if possible.
Exclusion criteria
âś•. Children and adolescents (less than 18 years old).
âś•. Subjects who are not willing or able to provide written consent.
âś•. Individuals with any significant medical history including skin disorders and eating disorders as determined by the investigator/physician.
âś•. Subjects on any substances affecting blood coagulation (including but not limited to aspirin and other non-steroid anti-inflammatory drugs, warfarin, vitamin E, fish oil, heparin, low-molecular weight heparin, novel anti-coagulants).